NO155880C - Analogifremgangsmaate til fremstilling av terapeutisk aktivt 2-(2'hydroksy-3'-(1,1-dimetylpropylamino)-propoksy)-baa-fenylpropionfenon. - Google Patents

Analogifremgangsmaate til fremstilling av terapeutisk aktivt 2-(2'hydroksy-3'-(1,1-dimetylpropylamino)-propoksy)-baa-fenylpropionfenon.

Info

Publication number
NO155880C
NO155880C NO83831339A NO831339A NO155880C NO 155880 C NO155880 C NO 155880C NO 83831339 A NO83831339 A NO 83831339A NO 831339 A NO831339 A NO 831339A NO 155880 C NO155880 C NO 155880C
Authority
NO
Norway
Prior art keywords
dimethylpropylamino
propoxy
hydroxy
preparation
phenylpropionphenon
Prior art date
Application number
NO83831339A
Other languages
English (en)
Other versions
NO155880B (no
NO831339L (no
Inventor
Gerd Petrik
Rolf Sachse
Original Assignee
Helopharm Petrik Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Helopharm Petrik Co Kg filed Critical Helopharm Petrik Co Kg
Publication of NO831339L publication Critical patent/NO831339L/no
Publication of NO155880B publication Critical patent/NO155880B/no
Publication of NO155880C publication Critical patent/NO155880C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
    • C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/32—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • C07C217/36—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by carbon atoms having at least two bonds to oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
NO83831339A 1981-08-25 1983-04-15 Analogifremgangsmaate til fremstilling av terapeutisk aktivt 2-(2'hydroksy-3'-(1,1-dimetylpropylamino)-propoksy)-baa-fenylpropionfenon. NO155880C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3133814A DE3133814C2 (de) 1981-08-25 1981-08-25 2-[2'-Hydroxy-3'-(1,1-dimethylpropylamino)-propoxy]-β-phenylpropiophenon, seine Säureadditionssalze und Arzneimittel
PCT/EP1982/000180 WO1983000688A1 (en) 1981-08-25 1982-08-24 2-ad2'-hydroxy-3'-(1,1-dimethylpropylamino)-propoxybd-beta-phenylpropiophenone, preparation and pharmaceutical compositions

Publications (3)

Publication Number Publication Date
NO831339L NO831339L (no) 1983-04-15
NO155880B NO155880B (no) 1987-03-09
NO155880C true NO155880C (no) 1987-06-17

Family

ID=6140190

Family Applications (1)

Application Number Title Priority Date Filing Date
NO83831339A NO155880C (no) 1981-08-25 1983-04-15 Analogifremgangsmaate til fremstilling av terapeutisk aktivt 2-(2'hydroksy-3'-(1,1-dimetylpropylamino)-propoksy)-baa-fenylpropionfenon.

Country Status (24)

Country Link
US (1) US4460605A (no)
EP (1) EP0074014B1 (no)
JP (1) JPS58501324A (no)
KR (1) KR870000957B1 (no)
AT (1) ATE8129T1 (no)
AU (1) AU555818B2 (no)
CA (1) CA1192224A (no)
CS (1) CS241511B2 (no)
DD (1) DD211783A5 (no)
DE (2) DE3133814C2 (no)
DK (1) DK156430C (no)
ES (1) ES515222A0 (no)
FI (1) FI71123C (no)
GR (1) GR77591B (no)
HU (1) HU193523B (no)
IL (1) IL66518A (no)
NO (1) NO155880C (no)
PL (1) PL135591B1 (no)
PT (1) PT75460B (no)
RO (1) RO87061B (no)
SU (1) SU1331424A3 (no)
WO (1) WO1983000688A1 (no)
YU (1) YU42792B (no)
ZA (1) ZA826025B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3226863A1 (de) * 1981-09-18 1983-04-07 Basf Ag, 6700 Ludwigshafen Aminopropanolderivate von 2-hydroxy-ss-phenyl-propiophenonen, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel
DE3309595A1 (de) * 1983-03-17 1984-09-20 Basf Ag, 6700 Ludwigshafen Neue aminopropanolderivate von 1-(2-hydroxy-phenyl)-3-phenyl-propanolen, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel
DE3328376A1 (de) 1983-07-21 1985-01-31 Helopharm W. Petrik & Co Kg, 1000 Berlin Aminopropanolderivate von 2-hydroxy-ss-phenyl-propiophenonen, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
DE3348170C2 (no) * 1983-07-21 1993-03-11 Helopharm W. Petrik Gmbh & Co Kg, 1000 Berlin, De
DE3343671A1 (de) * 1983-12-02 1985-06-20 Basf Ag, 6700 Ludwigshafen Aminopropanolderivate von substituierten 2-hydroxy-propiophenonen, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel
US5095151A (en) * 1985-05-21 1992-03-10 American Home Products Corporation Preparation of propranolol hydrochloride macrocrystals
DE3725273A1 (de) * 1987-07-30 1989-02-09 Basf Ag Verfahren zur synthese von enantiomeren des propafenons sowie diese enthaltende therapeutische mittel
US4954347A (en) * 1988-05-03 1990-09-04 Basf K & F Corp. Long lasting composition of propafenone and quinidine for treatment of cardiac conditions
DE3907512C2 (de) * 1989-03-08 1997-08-14 Laevosan Gmbh & Co Kg Neue Aryloxy-alkylamine, deren Herstellung und diese enthaltende Arzneimittel
DE3911069A1 (de) * 1989-04-06 1990-10-11 Knoll Ag Einkristalle von ss-phenylpropiophenonen
DE4000213A1 (de) * 1990-01-05 1991-07-11 Helopharm Petrik Co Kg O-hydroxy-ss-(1-naphthyl)-propiophenonderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US6168615B1 (en) 1998-05-04 2001-01-02 Micrus Corporation Method and apparatus for occlusion and reinforcement of aneurysms
ES2446390T3 (es) 2011-07-11 2014-03-07 Omya International Ag Partículas de carbonato de calcio hidrofobizadas
CN104262178A (zh) * 2014-09-28 2015-01-07 常州瑞明药业有限公司 盐酸普罗帕酮的合成方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2001431C3 (de) * 1970-01-06 1974-12-12 Helopharm W. Petrik & Co Kg, 1000 Berlin 2-(2'-Hydroxy-3'-alkylaminopropoxy)-Omega-phenyl-propiophenone und Verfahren zur Herstellung derselben

Also Published As

Publication number Publication date
NO155880B (no) 1987-03-09
GR77591B (no) 1984-09-25
DK156430C (da) 1990-01-15
HU193523B (en) 1987-10-28
KR870000957B1 (ko) 1987-05-14
JPS58501324A (ja) 1983-08-11
EP0074014A1 (de) 1983-03-16
ATE8129T1 (de) 1984-07-15
IL66518A (en) 1985-09-29
ES8400392A1 (es) 1983-11-01
KR840001124A (ko) 1984-03-28
YU42792B (en) 1988-12-31
DD211783A5 (de) 1984-07-25
NO831339L (no) 1983-04-15
PT75460B (en) 1984-11-19
DK178883D0 (da) 1983-04-22
CS241511B2 (en) 1986-03-13
PL135591B1 (en) 1985-11-30
WO1983000688A1 (en) 1983-03-03
AU555818B2 (en) 1986-10-09
CA1192224A (en) 1985-08-20
ZA826025B (en) 1983-07-27
DE3133814C2 (de) 1983-12-22
ES515222A0 (es) 1983-11-01
FI831388A0 (fi) 1983-04-22
SU1331424A3 (ru) 1987-08-15
RO87061B (ro) 1985-09-01
PT75460A (en) 1982-09-01
DK178883A (da) 1983-04-22
US4460605A (en) 1984-07-17
YU190782A (en) 1985-06-30
DK156430B (da) 1989-08-21
DE3133814A1 (de) 1983-03-10
EP0074014B1 (de) 1984-06-27
AU8711382A (en) 1983-03-03
RO87061A (ro) 1985-08-31
FI71123B (fi) 1986-08-14
PL238012A1 (en) 1983-03-28
JPS6240352B2 (no) 1987-08-27
FI71123C (fi) 1986-11-24
FI831388L (fi) 1983-04-22
DE3260301D1 (en) 1984-08-02

Similar Documents

Publication Publication Date Title
NO155880C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktivt 2-(2'hydroksy-3'-(1,1-dimetylpropylamino)-propoksy)-baa-fenylpropionfenon.
FI793238A (fi) Difenylbutyl-piperazinekarboxamider
SE8102194L (sv) Terapeutiskt aktiv organisk forening och farmaceutisk beredning innehallande denna
NO167658C (no) Analogifremgangsmaate for fremstilling av nye, terapeutiskaktive difenylpropylaminderivater.
NO157452C (no) Analogifremgangsmaate for fremstilling av et terapeutisk aktivt bispidinderivat.
ES554305A0 (es) Procedimiento para la fabricacion de derivados quinolilglicinamidas
FI863565A (fi) Foerfarande foer framstaellning av nya pyrrobenzimidazoler, pyrrolbenzoxazoler och pyrrolbenztiazoler.
SE8502525D0 (sv) 1,3-oxazolidine-2-one derivatives and processes for their preparation
NO162557C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive (pyrrol-1-yl)-fenyldihydropyridazinoner.
NO173137C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive forbindelser
NO910033D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 2-hydroksy-3-fenoksypropylaminoforbindelser.
ATE91418T1 (de) Mittel zur behandlung der herzinsuffizienz.
ES554115A0 (es) Procedimiento de preparacion de derivados del triazol y de sus sales de adicion con los acidos apropiados
SE8204670L (sv) Ny forening med antiulcerogen aktivitet, forfarande for dess framstellning och farmaceutisk beredning innehallande densamma
NO158676C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-furyl-3,4-dihydroisokinolin-derivater.
ES2044853T3 (es) Derivados de 1,4-di-hidro-piridina, procedimiento para su fabricacion y medicamentos que contienen estos compuestos.
RO82161A (ro) Procedeu pentru prepararea 2-(2-clor-4-ciclopropilfenilimino)-imidazolidinei
NO156866B (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktivt 17s, 17's-bisspartein og akseptable syreaddisjonssalter.